By Mill Chart
Last update: Aug 6, 2025
MetLife Inc (NYSE:MET) reported its second-quarter 2025 earnings, falling short of analyst expectations on both revenue and earnings per share (EPS). The insurance and financial services giant posted adjusted EPS of $2.02, missing the consensus estimate of $2.16, while revenue came in at $17.92 billion versus the expected $18.72 billion. This underperformance has triggered a negative market reaction, with shares declining nearly 6% in after-hours trading.
The weaker-than-expected results were driven by several factors, including less favorable underwriting margins, lower investment income from private equity, and higher net derivative losses due to stronger equity markets and rising interest rates.
The immediate after-hours sell-off suggests investor disappointment, particularly given the broader context of MetLife’s recent performance. Over the past month, the stock had already declined nearly 6%, and the latest earnings miss appears to have exacerbated concerns about near-term profitability.
CEO Michel Khalaf emphasized progress in MetLife’s "New Frontier" strategy, including strategic transactions with Chariot Re, Talcott Financial Group, and PineBridge Investments to bolster asset management and retirement solutions. The company also returned $900 million to shareholders via buybacks and dividends.
While MetLife did not provide explicit forward guidance, analysts currently estimate Q3 2025 revenue at $18.87 billion and full-year revenue at $76.13 billion. The lack of a strong upward revision in outlook may have contributed to the negative market sentiment.
For a deeper dive into MetLife’s earnings and future estimates, review the latest analyst projections here.
Disclaimer: This article is for informational purposes only and does not constitute investment advice.
NYSE:MET (10/16/2025, 10:09:04 AM)
79.81
-1.81 (-2.22%)
Find more stocks in the Stock Screener